Literature DB >> 33511646

Cerebral blood flow and acute episodes of Leigh syndrome in neurometabolic disorders.

Klervie Loiselet1, Benedetta Ruzzenente2,3, Charles-Joris Roux1, Giulia Barcia2, Alessandra Pennisi2, Isabelle Desguerre4, Agnès Rötig3, Arnold Munnich2,3, Nathalie Boddaert1,3.   

Abstract

AIM: To investigate cerebral blood flow (CBF) in acute episodes of Leigh syndrome compared with basal state in patients carrying pathogenic mitochondrial disease gene variants responsible for neurometabolic disorders.
METHOD: Arterial spin labelling (ASL) magnetic resonance imaging (MRI) sequences were used to measure CBF in 27 patients with mitochondrial respiratory chain enzyme deficiencies, ascribed to pathogenic variants of reported disease genes who were undergoing either urgent neuroimaging for acute episodes of Leigh syndrome (Group I: 15 MRI, seven females, eight males; mean age 7y; range 7mo-14y) or routine brain MRI (Group II: 15 MRI, eight females, seven males; mean age 5y 2mo; range 2mo-12y).
RESULTS: Patients displayed markedly increased CBF in the striatum (2.8-fold greater, p<0.001 [1.05-2.53]) during acute episodes of Leigh syndrome compared to basal conditions. Detection of elevated CBF preceded identification of structural MRI lesions in four out of 15 cases.
INTERPRETATION: Our results suggest that increased CBF is an overt hallmark of Leigh syndrome episodes and ASL MRI sequences should facilitate early diagnosis of acute episodes of Leigh syndrome, especially during the first attack in young children, when structural MRI is insufficiently informative.
© 2021 Mac Keith Press.

Entities:  

Year:  2021        PMID: 33511646     DOI: 10.1111/dmcn.14814

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  1 in total

Review 1.  On the dynamic and even reversible nature of Leigh syndrome: Lessons from human imaging and mouse models.

Authors:  Melissa A Walker; Maria Miranda; Amanda Allred; Vamsi K Mootha
Journal:  Curr Opin Neurobiol       Date:  2021-10-14       Impact factor: 7.070

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.